Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

RELIANCE CHEMOTEX 2021-22 Annual Report Analysis
Mon, 19 Sep

RELIANCE CHEMOTEX has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

RELIANCE CHEMOTEX Income Statement Analysis

  • Operating income during the year rose 41.5% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 79.3% YoY during the fiscal. Operating profit margins witnessed a fall and down at 11.5% in FY22 as against 9.0% in FY21.
  • Depreciation charges increased by 12.3% and finance costs increased by 25.9% YoY, respectively.
  • Other income grew by 46.6% YoY.
  • Net profit for the year grew by 161.6% YoY.
  • Net profit margins during the year grew from 2.7% in FY21 to 5.0% in FY22.

RELIANCE CHEMOTEX Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 2,556 3,618 41.5%
Other income Rs m 45 66 46.6%
Total Revenues Rs m 2,601 3,684 41.6%
Gross profit Rs m 231 414 79.3%
Depreciation Rs m 76 85 12.3%
Interest Rs m 96 121 25.9%
Profit before tax Rs m 104 274 164.0%
Tax Rs m 34 92 168.7%
Profit after tax Rs m 69 181 161.6%
Gross profit margin % 9.0 11.5
Effective tax rate % 33.1 33.7
Net profit margin % 2.7 5.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

RELIANCE CHEMOTEX Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 1 billion as compared to Rs 1 billion in FY21, thereby witnessing an increase of 35.8%.
  • Long-term debt stood at Rs 471 million as compared to Rs 339 million during FY21, a growth of 39.0%.
  • Current assets rose 26% and stood at Rs 1 billion, while fixed assets rose 29% and stood at Rs 2 billion in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 3 billion as against Rs 3 billion during FY21, thereby witnessing a growth of 28%.

RELIANCE CHEMOTEX Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 1,044 1,214 16.3
 
Current Liabilities Rs m 1,042 1,415 35.8
Long-term Debt Rs m 339 471 39.0
Total Liabilities Rs m 2,644 3,380 27.9
 
Current assets Rs m 1,075 1,357 26.3
Fixed Assets Rs m 1,569 2,023 28.9
Total Assets Rs m 2,644 3,380 27.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RELIANCE CHEMOTEX Cash Flow Statement Analysis

  • RELIANCE CHEMOTEX's cash flow from operating activities (CFO) during FY22 stood at Rs 594 million, an improvement of 118.6% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -736 million, an improvement of 71.6% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs 139 million on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs -3 million from the Rs -5 million net cash flows seen during FY21.

RELIANCE CHEMOTEX Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 272 594 118.6%
Cash Flow from Investing Activities Rs m -429 -736 -
Cash Flow from Financing Activities Rs m 153 139 -8.7%
Net Cash Flow Rs m -5 -3 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for RELIANCE CHEMOTEX

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 24.0, an improvement from the EPS of Rs 9.2 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 190.3, stands at 7.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.2 times, while the price to sales ratio stands at 0.4 times.
  • The company's price to cash flow (P/CF) ratio stood at 6.1 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 339.0 479.8
TTM Earnings per share Rs 9.2 24.0
Diluted earnings per share Rs 9.2 24.0
Price to Cash Flow x 4.0 6.1
TTM P/E ratio x 8.4 7.9
Price / Book Value ratio x 0.5 1.3
Market Cap Rs m 536 1,629
Dividends per share (Unadj.) Rs 2.0 2.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for RELIANCE CHEMOTEX

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.0x during FY22, from 1.0x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 3.3x during FY22, from 2.1x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 14.9% during FY22, from 6.6% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 23.4% during FY22, from 14.5% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 9.0% during FY22, from 6.3% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.0 1.0
Debtors’ Days Days 152 55
Interest coverage x 2.1 3.3
Debt to equity ratio x 0.3 0.4
Return on assets % 6.3 9.0
Return on equity % 6.6 14.9
Return on capital employed % 14.5 23.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how RELIANCE CHEMOTEX has performed over the last 5 years, please visit here.

RELIANCE CHEMOTEX Share Price Performance

Over the last one year, RELIANCE CHEMOTEX share price has moved up from Rs 165.0 to Rs 190.3, registering a gain of Rs 25.3 or around 15.3%.

Overall, the S&P BSE SENSEX is up 0.6% over the year.

(To know more, check out historical annual results for RELIANCE CHEMOTEX and quarterly results for RELIANCE CHEMOTEX)

Annual Report FAQs

What is the current share price of RELIANCE CHEMOTEX?

RELIANCE CHEMOTEX currently trades at Rs 205.4 per share. You can check out the latest share price performance of RELIANCE CHEMOTEX here...

What was the revenue of RELIANCE CHEMOTEX in FY22? How does it compare to earlier years?

The revenues of RELIANCE CHEMOTEX stood at Rs 3,684 m in FY22, which was up 41.6% compared to Rs 2,601 m reported in FY21.

RELIANCE CHEMOTEX's revenue has grown from Rs 2,850 m in FY18 to Rs 3,684 m in FY22.

Over the past 5 years, the revenue of RELIANCE CHEMOTEX has grown at a CAGR of 6.6%.

What was the net profit of RELIANCE CHEMOTEX in FY22? How does it compare to earlier years?

The net profit of RELIANCE CHEMOTEX stood at Rs 181 m in FY22, which was up 161.6% compared to Rs 69 m reported in FY21.

This compares to a net profit of Rs 93 m in FY20 and a net profit of Rs 41 m in FY19.

Over the past 5 years, RELIANCE CHEMOTEX net profit has grown at a CAGR of 62.5%.

What does the cash flow statement of RELIANCE CHEMOTEX reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of RELIANCE CHEMOTEX reveals:

  • Cash flow from operations increased in FY22 and stood at Rs 594 m as compared to Rs 272 m in FY21.
  • Cash flow from investments decreased in FY22 and stood at Rs -736 m as compared to Rs -429 m in FY21.
  • Cash flow from financial activity decreased in FY22 and stood at Rs 139 m as compared to Rs 153 m in FY21.

Here's the cash flow statement of RELIANCE CHEMOTEX for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations107258216272594
From Investments-1-2-75-429-736
From Financial Activity-112-257-134153139
Net Cashflow-6-16-5-3

What does the Key Ratio analysis of RELIANCE CHEMOTEX reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of RELIANCE CHEMOTEX reveals:

  • Operating profit margins witnessed a fall and down at 11.5% in FY22 as against 9.0% in FY21.
  • Net profit margins grew from 2.7% in FY21 to 5.0% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.4 as compared to 0.3 in FY21.

Here's the ratio/financial analysis of RELIANCE CHEMOTEX for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)6.87.99.59.011.5
Net Profit Margin (%)0.91.33.12.75.0
Debt to Equity Ratio (x)0.70.80.30.30.4

 

Equitymaster requests your view! Post a comment on "RELIANCE CHEMOTEX 2021-22 Annual Report Analysis". Click here!